Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction
- 23 July 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 327 (4), 227-233
- https://doi.org/10.1056/nejm199207233270403
Abstract
The Cardiac Arrhythmia Suppression Trial (CAST) tested the hypothesis that the suppression of asymptomatic or mildly symptomatic ventricular premature depolarizations in survivors of myocardial infarction would decrease the number of deaths from ventricular arrhythmias and improve overall survival. The second CAST study (CAST-II) tested this hypothesis with a comparison of moricizine and placebo.Keywords
This publication has 21 references indexed in Scilit:
- The cardiac arrhythmia suppression trial: First CAST … then CAST-IIJournal of the American College of Cardiology, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboThe New England Journal of Medicine, 1991
- Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were availableThe American Journal of Cardiology, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionThe New England Journal of Medicine, 1989
- Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot Study)The American Journal of Cardiology, 1989
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- How the university cardiologist treats ventricular premature beats: A nationwide survey of 65 University Medical CentersAmerican Heart Journal, 1985
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-upThe American Journal of Cardiology, 1984
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Effect of antiarrhythmic drugs on mortality after myocardial infarctionThe American Journal of Cardiology, 1983